Intramuscular Hydroxyprogesterone Caproate and Placenta Previa
Palabras clave
Abstracto
fechas
Verificado por última vez: | 05/31/2018 |
Primero enviado: | 04/21/2017 |
Inscripción estimada enviada: | 04/21/2017 |
Publicado por primera vez: | 04/25/2017 |
Última actualización enviada: | 06/29/2018 |
Última actualización publicada: | 07/02/2018 |
Fecha de inicio real del estudio: | 03/31/2016 |
Fecha estimada de finalización primaria: | 02/28/2017 |
Fecha estimada de finalización del estudio: | 03/31/2017 |
Condición o enfermedad
Intervención / tratamiento
Drug: 17α hydroxy progesterone caproate group
Fase
Grupos de brazos
Brazo | Intervención / tratamiento |
---|---|
Active Comparator: 17α hydroxy progesterone caproate group | Drug: 17α hydroxy progesterone caproate group where patients will have a 17α hydroxy progesterone caproate intramuscular injection every week starting from 24 weeks of gestation till completed 37 weeks |
No Intervention: No intervention group |
Criterio de elegibilidad
Edades elegibles para estudiar | 20 Years A 20 Years |
Sexos elegibles para estudiar | Female |
Acepta voluntarios saludables | si |
Criterios | Inclusion Criteria: 1. Estimated gestational age is ranging between 24 weeks and 26 week's gestation 2. Singleton pregnancy. 3. Placenta previa; either major or minor degrees. 4. Placenta previa with minimal vaginal bleeding or haven't any vaginal bleeding. 5. For outpatient follow ups, women should be living in a nearby area to make follow-up and early transportation are reasonably possible. 6. Accepting to participate in the study. Exclusion Criteria: 1. Definite rupture of membranes. 2. Established preterm labor. 3. Severe attack of bleeding requiring an immediate intervention. 4. Fetal heart rates instability or non reassuring 5. Intrauterine fetal death or major fetal anomalies. 6. If associated with abruptio placentae 7. Patients with known bleeding disorders or on anticoagulant therapy 8. Patents with severe medical disorders as preeclamptic toxemia, diabetes mellitus, hepato-renal impediment …etc 9. The presence of reported side effects in the mother from 17α hydroxy progesterone caproate like hypersensitivity reactions, cough, dyspnea, and diabetes. |
Salir
Medidas de resultado primarias
1. number of women delivered before 37 weeks [13 weeks]